Biocapitol

Bio Venture Intelligence

Overview

Submit

Pipeline

Data Rooms

Deal Memo

Market Map

Pricing

Buyer Pack

Capital Pulse

+18.4%

Early-stage biotech deal activity accelerated this week.

Watchlist

Signals

Investor Login

Biocapitol

Biotech venture intelligence platform for startup discovery, data room scoring, investor matching and AI-style deal memos.

Export Report

Submit Startup

Request Demo

Premium biotech investor SaaS demo

Discover high-signal biotech startups and generate investor-ready deal intelligence.

Biocapitol helps investors, labs, accelerators and life sciences teams discover biotech companies, score data rooms, track commercialization momentum and produce AI-style deal memos.

Explore Pipeline

Submit Biotech Startup

Generate Deal Memo

Signal Momentum

91 / 100

Biotech discovery pipeline is showing strong investor intent.

Tracked Startups

1,280+

Across biotech and adjacent sectors

Open Deals

Seed to Series B opportunities

Licensing Leads

University and lab opportunities

Active Investors

Premium buyer-side users

AI Deal Memos

Generate investor-style summaries with thesis, risk and next-step logic.

Investor Match

Match startups with likely funds, scouts and specialist capital groups.

Data Room Scoring

Track pitch deck, IP, clinical, regulatory and financial readiness.

Market Intelligence

Map emerging biotech sectors and commercial timing windows.

Founder submission

Upload a biotech pitch deck, IP summary or funding memo.

Founders can submit a biotech startup and upload materials such as pitch decks, clinical summaries, patent notes, regulatory pathways or funding memos. Biocapitol turns the submission into a venture profile, data room score, investor match and AI deal memo.

Open Submit Flow

↑

Upload pitch deck / IP pack / memo

Demo upload area for biotech pitch decks, data room files, clinical notes, licensing packs and investor memos.

Score data room

Pitch, IP, clinical, regulatory and financial readiness.

Generate memo

Create a thesis, risk notes and next-step deal summary.

Match investors

Suggest funds, scouts and strategic capital groups.

Add to market map

Place the startup in the sector intelligence layer.

Startup Discovery

Venture pipeline

Export PDF

All

Biotech

Synthetic Bio

MedTech

Climate Bio

Diagnostics

HelixNova

Score 91

Hiring + clinical momentum

Watchlist

Biotech

Series A

$11.2M

Clinical

Therapeutics platform showing translational growth, hiring expansion and strong investor visibility.

View Profile

Deal Memo

Data Room

SynThera Labs

Score 87

Patent activity up

Watchlist

Synthetic Bio

Seed

$4.8M

Synthetic biology company with rising patent momentum and growing interest from specialist funds.

View Profile

Deal Memo

Data Room

MiraCell Bio

Score 82

University spinout

Watchlist

Biotech

Pre-Seed

Germany

$1.6M

Research

Early-stage university spinout with promising IP and strong commercialization potential.

View Profile

Deal Memo

Data Room

CarbonLeaf Systems

Score 90

Strategic partnerships

Watchlist

Climate Bio

Series A

Netherlands

$13.5M

Partnering

Climate bio venture building strong industrial partnerships with clear commercial pathways.

View Profile

Deal Memo

Data Room

NovaDx

Score 84

Regulatory pathway active

Watchlist

Diagnostics

Seed

France

$3.2M

Preclinical

Diagnostics startup progressing through regulatory preparation with strong market timing.

View Profile

Deal Memo

Data Room

OrthoPulse

Score 89

Enterprise pilot expansion

Watchlist

MedTech

Series B

Sweden

$22M

Funded

MedTech platform scaling enterprise pilots and positioning for broader healthcare rollout.

View Profile

Deal Memo

Data Room

Investor Activity

Live feed

BioForge Ventures viewed 12 synthetic bio profiles

High activity across seed-stage discovery

11 min ago

New licensing packet uploaded by MiraCell Bio

University-origin IP now accessible in data room

34 min ago

CarbonLeaf Systems moved to diligence shortlist

Commercial traction and strategic interest increased

1 hr ago

NovaDx flagged by regulatory signal engine

Monitoring pathway update and timing window

3 hrs ago

Investor Match

Best-fit capital

North Bridge Bio

94%

BioForge Ventures

88%

Catalyst Health Partners

81%

Data Rooms

Investor readiness score

Preview Data Room

Data Room Score

82%

Strong foundation. Financial model and regulatory pathway are the missing diligence items.

Pitch deck uploaded

IP summary uploaded

Clinical overview uploaded

Financial model missing

Regulatory pathway missing

AI Deal Memo

Investor-style thesis, risks and next actions

Open Memo Modal

HelixNova

Stage: Series A

Sector: Biotech

Signal: Hiring + clinical momentum

Why it matters: Therapeutics platform showing translational growth, hiring expansion and strong investor visibility.

Key risk: regulatory timing, capital intensity and proof depth.

Next step: request data room and schedule founder call.

Market Map

Hot sectors this month

Export Map

+28%

Synthetic Biology

Patent and platform activity rising.

+16%

Diagnostics

Regulatory and hospital demand active.

+21%

Climate Bio

Industrial partnerships accelerating.

+13%

Cell Therapy

Clinical momentum and capital attention.

Pipeline Board

Current internal flow

MiraCell Bio

Sourced

University spinout with early IP visibility

NovaDx

Review

Regulatory timing makes this one worth monitoring

SynThera Labs

Diligence

Patent activity and syndicate interest rising

CarbonLeaf Systems

Priority

Commercial traction and strategic fit strong

Recent Funding

Deal room flow

HelixNova

Closed

Series A • $11.2M

Lead investor: North Bridge Bio

CarbonLeaf Systems

Closed

Series A • $13.5M

Lead investor: Green Frontier Capital

SynThera Labs

In diligence

Seed Extension • $2.1M

Lead investor: BioForge Ventures

NovaDx

Opened

Seed • $3.2M

Lead investor: Catalyst Health Partners

Monetization

Premium SaaS pricing

Founder

$99/mo

Startup profile

Basic data room

Investor visibility

Milestone posting

Get Started